Italy refuses to give up hope on EMA HQ
January 30, 2018Medical Communications, Research and Development EMA, amsterdam, biotech, drugs, pharma, pharmaceutical
It is no secret that Milan was not best pleased that it was pipped to the post to host the …
Read Pharmafocus January/February 2018 edition online now!
January 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Ablynx, Alex Azr, Celgene, Pharmafocus, Sanofi, UK, artificial intelligence, bioverativ, brexit, juno therapeutics, multiple myeloma, serialisation
With the holiday period a distant memory by now, Pharmafocus is back with its January/febraury edition. It’s hard to imagine …
Philippines’ Department of Health demands full refund of $70m Dengvaxia programme from Sanofi
January 30, 2018Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
In the latest development in Sanofi’s Philippines dengue vaccine scandal, the nation’s Department of Health has demanded that the French …
Apotex President resigns amidst Founder’s murder and allegations of accepting Teva secrets
January 30, 2018Manufacturing and Production, Medical Communications Apotex, Jeremy Desai, Teva, pharma
Following the alleged murder of its founder Barry Sherman and his wife in December last year, Canada’s largest generic drug …
Celgene Executive Chairman Bob Hugin to retire
January 30, 2018Manufacturing and Production, Medical Communications Bob Hugin, Celgene, pharma
Fresh from its acquisition of Juno Therapeutics, Celgene has announced that its Executive Chairman Bob Hurgin is to retire effective …
FDA revises methods, after public outrage at testing of monkeys
January 29, 2018Manufacturing and Production, Medical Communications FDA, biotech, drugs, pharma, pharmaceutical
The story broke in September of last year that the FDA was testing nicotine addiction in squirrel monkeys and that …
Santhera’s Raxone rejected in Europe for Duchenne muscular dystrophy
January 29, 2018Sales and Marketing Duchenne Muscular Dystrophy, EMA, Europe Santhera, pharma
While the EMA’s Committee for Medicinal products for Human Use (CHMP) recommended a spree of treatments over the past week, …
Delivering the life sciences agenda: Easy as ABC
January 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life sciences strategy, biotech, brexit, drugs, pharma, pharmaceutical
Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical Campus …
Radioactive drug given approval by the FDA
January 29, 2018Sales and Marketing Advanced Accelerator Applications, Lutathera, Novartis, biotech, drugs, pharma, pharmaceutical
The FDA has approved Lutathera, marking the first time that the agency has given approval for a radioactive drug or …
EMA committee recommends seven therapies from Roche, GSK, MSD and more
January 29, 2018Sales and Marketing Biocon, Chiesi, Chugai, GSK, GlaxoSmithKline, MSD, Mylan, Roche, Sanofi, pharma
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has voiced its recommendation of a raft of …
Brexit Health Alliance warns of UK at back of the medicine queue
January 29, 2018Medical Communications, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical
The Brexit Health Alliance (BHA) has cautioned that unless a favourable deal is struck, the UK could end Brexit negotiations …
Sanofi swoops for Ablynx in $4.8bn deal
January 29, 2018Sales and Marketing Ablynx, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi has moved quickly to tie up a deal with Ablynx for $4.8 billion, when it looked more likely that …
Top Ten most popular articles on Pharmafile.com this week
January 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abcam, Alzheimer's, Dr Reddy's, GSK, J&J, JJ, Reckitt Benckiser, Remicade, Sanofi, influenza, opioid crisis, opioids, top ten, valproate
As we come to the end of January, it’s Friday again – time for another rundown of the top ten …
NICE urges curbing the use of antibiotics for sore throats
January 26, 2018Medical Communications Antibiotics, NICE, biotech, drugs, pharma, pharmaceutical
In a study published by the BMJ a few years ago, it was found that antibiotics were prescribed in 60% …
AZ’s triple therapy inhaler hits 8 out of 9 endpoints
January 26, 2018Medical Communications, Research and Development AstraZeneca, COPD, biotech, drugs, pharma, pharmaceutical
AstraZeneca has made a brief announcement that its triple therapy inhaler manage to successfully hit eight of nine primary endpoints …
iQOS heat-not-burn electronic tobacco product doesn’t reduce health risk, FDA says
January 26, 2018Medical Communications, Sales and Marketing FDA, Philip Morris, iQOS, pharma, smoking, tobacco
An advisory panel of the FDA has judged that US tobacco firm Philip Morris International (PMI) has not been able …
Biogen announces acquisition along with financials, but it’s tiny
January 26, 2018Medical Communications, Sales and Marketing Biogen, Karyopharm, biotech, drugs, pharma, pharmaceutical
Biogen is one those companies, like Sanofi until its recent Bioverativ acquisition, that has real pressure to make a big …
Senescent cell findings provides Parkinson’s treatment clue
January 25, 2018Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
Senescent cells are the dormant state that cells shift to in response to certain stressors, it is thought that they …
Spark hands over Luxturna rights outside US to Novartis for $170m
January 25, 2018Sales and Marketing Luxturna, Novartis, Spark Therapeutics, pharma
Novartis has confirmed a deal worth a potential $170 million with Spark Therapeutics to develop and commercialise its gene therapy …
Amyloid pathway doubts after latest Alzheimer’s failure
January 25, 2018Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
There has been another drug failure in a large Phase 3 that once again crushes a hope for a possible …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
